Entheon Biomedical

When it comes to treating addiction, the rate of success is so low that society has been conditioned to accept – and even expect – failure. This manner of thinking is both unacceptable and counterproductive. There is a need for an alternative approach, that addresses the human cost of addiction for individuals, families and society at large. We are developing a DMT-assisted therapeutic protocol that will be specifically tailored to address the core mechanisms underlying drug-seeking and using behavior. Our chief aim is to provide an effective and scalable therapeutic protocol that will serve as a vital resource for those afflicted with a substance-use disorder, and who are wanting to reclaim their lives.

Website

https://entheonbiomedical.com

External link for Entheon Biomedical

Industry

Pharmaceutical Manufacturing

Company size

11-50 employees

Headquarters

Vancouver, BC

Type

Public Company

Founded

2019

Specialties

Mental Health Reasearch, Mental Health, Psilocybin Research, Alternative Therapies, Addiction Treatment, Addiction, substance use disorder, DMT, Psychedelics, addiction, drug discovery, psychedelic assisted psychotherapy, 5 MeO DMT, biotechnology, and pharmaceuticals